PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences, today announced GAAP earnings per share from continuing operations of $.20 on revenue of $361.9 million for the third quarter ended October 2, 2005. This third quarter EPS represents an increase of 43% over GAAP earnings per share of $.14 in the third quarter of 2004.
